- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Curry, J.
- Articles by Glickman, B. W.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Curry, J.
- Articles by Glickman, B. W.
Influence of Sex, Smoking and Age on Human hprt Mutation Frequencies and Spectra
John Currya, Larissa Karnaoukhovaa, Gabriel C. Guenettea, and Barry W. Glickmanaa Centre for Environmental Health and the Department of Biology, University of Victoria, Victoria, British Columbia V8W 3N5, Canada
Corresponding author: John Curry, Centre for Environmental Health, University of Victoria, P.O. Box 3020, Victoria, British Columbia V8W 3N5, Canada., jcurry{at}uvic.ca (E-mail)
Communicating editor: G. B. GOLDING
| ABSTRACT |
|---|
Examination of the literature for hprt mutant frequencies from peripheral T cells yielded data from 1194 human subjects. Relationships between mutant frequency, age, sex, and smoking were examined, and the kinetics were described. Mutant frequency increases rapidly with age until about age 15. Afterward, the rate of increase falls such that after age 53, the hprt mutant frequency is largely stabilized. Sex had no effect on mutant frequency. Cigarette smoking increased mean mutant frequency compared to nonsmokers, but did not alter age vs. mutant frequency relationships. An hprt in vivo mutant database containing 795 human hprt mutants from 342 individuals was prepared. No difference in mutational spectra was observed comparing smokers to nonsmokers, confirming previous reports. Sex affected the frequency of deletions (>1 bp) that are recovered more than twice as frequently in females (P = 0.008) compared to males. There is no indication of a significant shift in mutational spectra with age for individuals older than 19 yr, with the exception of A:T
C:G transversions. These events are recovered more frequently in older individuals.
AGING occupies a central position in health concerns. While the causes of aging are undoubtedly complex, it has been suggested that somatic mutations play a central role in the process (for review see ![]()
![]()
![]()
![]()
![]()
![]()
![]()
Another potential mechanism of aging involves DNA methylation (![]()
T/A transitions. Approximately 7 x 106 C
T transitions per human genome per division occur (![]()
![]()
More than 150 human genetic diseases have been characterized by ![]()
![]()
![]()
![]()
![]()
![]()
Current techniques permit the assessment of in vivo human somatic mutation frequencies. In addition, sequence characterization of mutations provides insight into their origin. With these advances, it has become possible to assess the influence of aging on both mutation frequency and mutational spectra. One of the targets of choice for monitoring mutations in humans is the hypoxanthine-guanine phosphoribosyltransferase (hprt) gene. Used in peripheral T cells, the hprt gene is nonessential, and all classes of mutation can be recovered. In vivo, T cell hprt mutants can be selected and quantified by their resistance to the base analogue 6-thioguanine (~10 µM), as used in the T cell clonal assay (![]()
Human populations demonstrate hprt mutant frequency (MF) values that range over two orders of magnitude (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Consequences of tobacco smoking on MF have been widely studied, with enigmatic results. ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Many investigators report a linear increase of hprt MF with subject age (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Other studies using different loci have also demonstrated linear age vs. MF relationships. Frequency of mutations at the HLA-A locus were found to increase with age from a mean of 0.71 x 10-5 in neonates to 6.5 x 10-5 in the elderly (age >60 yr, ![]()
![]()
/ß T-cell receptor (TCR) genes.
While the effect of age on mutant frequency has been the subject of several studies, the effect of aging on the mutational specificity of spontaneously arising mutants has not been well studied. The mutational spectrum of hprt is affected by age (![]()
![]()
![]()
| MATERIALS AND METHODS |
|---|
Mutant frequency analysis:
A database containing published hprt MF data was constructed, including unpublished MF data from this laboratory. A total of 1194 individual subjects ranging in age from 0 to 85 yr were identified from the available literature. The MF dataset is available upon request. An overview of the MF dataset by author is given in Table 1. Pretreatment cancer patients were included, as those studies (![]()
![]()
![]()
|
Cloning efficiencies in the mutant frequency dataset were found to vary substantially between laboratories (n = 1194, mean CE = 40.5 ± 21.6%). Many factors are likely to contribute to this wide variation. Analysis of the effect of smoking status, sex, or age on cloning efficiency did not reveal any significant trends. For this reason, CEs are not considered during any of the age and MF analyses and are not reported henceforth.
Mutation frequency (MuF) is the frequency of independent mutational events that occur in a subject rather than the frequency of mutants that may arise from one mutational event by way of in vivo T cell clonal expansion. Within our own data, we corrected two subjects' mutant frequencies to estimated mutation frequencies by correcting for clonality using unique TCR rearrangements (![]()
![]()
![]()
Analyses were performed using the commercial statistical software packages Statistica (Statsoft, Tulsa, OK) and SAS (V6.12, SAS Institute, Cary, NC). Regression analyses of mutant frequencies are based upon their natural logarithms, as these data are skewed (![]()
![]()
![]()
hprt mutational spectra analysis:
Mutational database construction:
Release five of the hprt mutant database was obtained from Mutabase Software (Durham, NC). All somatic mutants from human subjects were identified, but only mutants characterized by cDNA or multiplex PCR methods were selected from the hprt mutant database. Unpublished mutant spectra characterized by this laboratory (n = 76; L. G. KARNAOUKHOVA, K. S. WILSON and B. W. GLICKMAN (unpublished data) were also included.
Recent publications not yet included in the hprt mutant database were also added. Records from smokers, nonsmokers, and those with unknown smoking status were included, and these records were then reorganized to include three new fields: age, sex, and subject ID. This additional information required examination of the original publications, and it was necessary to determine the actual number of individuals from which the data were derived. Each mutant was also checked for accuracy against the original publication. Records with no age data were excluded from the hprt mutant dataset.
Mutants containing more than one mutation are described solely as complex. The original hprt database describes such mutations with multiple records. Mutants identified with truncated cDNAs or aberrant exon splicings were identified as splice mutations. Splice mutations for which the actual mutation had been determined by genomic DNA sequencing were identified by the presumed causative mutation. Uncharacterized splice mutations, though reported in the following tables, were excluded from further analysis (n = 188).
Analysis and the elimination of reporting bias:
Mutations collected for the analyses were obtained from several laboratories using either cDNA or multiplex PCR methods for the molecular characterization of mutants. As differences in these two methods may result in the unequal reporting of mutation classes or the unequal classification of mutations, a potential for bias exists. An Adams Skopek Monte Carlo test (![]()
Mutational spectra for smokers and nonsmokers were tested for differences. Similar mutational spectra for males and females were generated and tested. Finally, mutational spectra for several age groups were identified. For example, the dataset was partitioned into two age groups (437 and 3880 yr) and further into three and four age groups, with roughly equal numbers of mutants where possible. As the mutant database contained only two mutant sequences obtained from a young individual (4 yr old), no spectra analysis for individuals <19 yr old was attempted.
Mutational spectra were compared using the Adams Skopek Monte Carlo test. Mutational spectra were further evaluated using Fisher's exact test to examine specific mutational classes. Chi-square analysis was used in comparisons where the Fisher's exact test could not be performed.
| RESULTS |
|---|
Mutant frequency analysis:
Influence of sex on ln MF:
Differences in mean age and ln MF between males and females were tested using a t-test. As noted in Table 1, the sex of some subjects was not reported in the literature. Distribution of age between males and females was significantly different (P < 10-6). Cord blood samples (age = 0) are overrepresented in the male population (n = 47) as compared to the female population (n = 9), and result in a lower mean age for males. To obtain similarly distributed ages for the comparison of ln MF, the cord blood samples were excluded from the analysis. Although the mean age of female subjects remained significantly higher (P = 0.001) than that of males, ln MF was not significantly different between the sexes. As sex had no influence on ln MF, both sexes were combined to assess any effects of smoking.
Influence of smoking on ln MF: Differences between the ln MF of individuals who smoke tobacco and nonsmokers were tested for significance. Mean age was significantly different between smokers and nonsmokers (P < 10-6). Subjects 16 yr old or younger were excluded from this analysis, as they mainly comprised nonsmokers and significantly lowered the mean age of the group. With this exclusion, no significant difference in the mean age between the smoking and nonsmoking groups was observed. However, the smoking population had a significantly higher mean ln MF compared to the nonsmoking group (P = 0.0004).
To further explore the difference in the mean ln MF between smokers and nonsmokers, these two groups were subdivided by sex. After subjects 16 yr old or younger were excluded from the analysis, mean ages were not significantly different, except between male and female nonsmokers (P = 0.0001). Significant differences in the mean ln MF were observed only between male smokers and nonsmokers (P = 0.005), as well as between male nonsmokers and female smokers (P = 0.001). Male nonsmokers were noted to have the lowest ln MF among the four groups. Surprisingly, no significant difference was detected between the female smokers and nonsmokers.
Influence of age on ln MF: Results of several linear regression analyses are reported (Table 2). In the first regression, all data were included in the analysis of age vs. ln MF. The dependent variable was ln MF, and age was the independent variable. Correlation coefficients of the linear age-ln MF relationships for males and females are significantly different (P = 0.007). As previously noted, the mean age of male subjects was significantly lower than that of females. The male group contains significantly more MF determinations from cord blood samples (males n = 84, females n = 35), which partially accounts for the lower male mean age as compared to females. After excluding cord blood samples from both male and female linear age ln MF regressions, there was no significant difference in the correlation coefficients. The regression lines are nearly identical, as indicated by the intercepts and slopes (Table 2).
|
Linear regressions for smokers and nonsmokers revealed no significant differences in the correlation coefficients, but only after subjects 16 yr old or younger were excluded from the analysis. Smoking and nonsmoking age vs. ln MF relationships produce identical slopes, but the smoking group intercept is ~8% higher (Table 2).
Consistent with previous observations (![]()
|
Mutational spectra analysis:
A total of 795 independent mutations were collected from 342 individuals, and a summary of the mutational data assembled is listed by publication (Table 3). The complete hprt mutant dataset is available upon request. The mean age of these 298 individuals (excludes subjects that only presented uncharacterized splice mutants) is 40.3 ± SD 15.2 yr. Mutations were from individuals older than 18 yr, with the exception of two mutations from a 4-yr-old. Hence, the analysis is limited to the examination of changes in mutational specificity that occur exclusively in adults. As the majority of mutations (n = 513) have been obtained from the 236 male subjects, this unfortunately limits the analysis of the spectra for the effect of sex. Summary information regarding the subject samples by spectra groupings is shown (Table 4).
|
|
Test for dataset bias:
When each author dataset was tested against the remainder of the hprt mutant dataset using the Monte Carlo test, several demonstrated significant differences. In particular, the data of ![]()
![]()
![]()
![]()
![]()
![]()
Differential characterization of exon splice mutations represents the most consistent bias. Where causative mutations responsible for exon splice mutations were reported in the literature, the causative mutation was listed in the mutant data base. As some authors did not further characterize exon splice mutants while others did, this class of mutation could possibly bias the dataset. For example, a group of mutants where the causative mutations were determined would be different from a group where no further characterization of exon splice mutants was attempted. To avoid this potential bias, splice mutants that have not been further characterized are not considered. Finally, the spectrum of mutations obtained from fully characterized splice mutants could differ from those mutations that do not affect splicing. However, comparison of the mutational spectra from characterized exon splice mutations against mutations that do not affect splicing revealed that these spectra are identical in terms of the other classes of mutations.
Influence of smoking on spectra:
The smoking and nonsmoking groups were nearly identical in terms of age distribution (Table 4). Mutants were sorted into those from smokers (248 independent mutants) and nonsmokers (369 independent mutants), and the two spectra were compared (Table 5). Results of the Monte Carlo test revealed no significant differences. A barely significant difference in the frequency of G:C
A:T between smokers and nonsmokers was detected using Fisher's exact test (two-tailed, P = 0.05).
|
A total of 87 independent mutants (not including the uncharacterized splice mutations; 85 from smokers) were obtained from lung cancer patients (![]()
![]()
A:T transitions between smokers and nonsmokers could be detected. As a result, the smoking and nonsmoking mutational spectra datasets have been combined for further analysis.
Influence of sex on spectra:
Few datasets are large enough to examine the influence of sex on mutational specificity. Subject age distribution (Table 4) was essentially equal; however, relatively few mutants were recovered from females subjects (n = 104) as compared to males (n = 513). Monte Carlo analysis did demonstrate a significant difference between the two spectra (Table 5; P = 0.008; 95% confidence limits 0.0060.01). Each mutation class was tested alone using Fisher's exact test (two-tailed). There were significant differences in the frequency of G:C
A:T (P = 0.02) and A:T
T:A (P = 0.04) base substitutions between males and females. Caution is warranted, however, when considering the limited set of mutants obtained from female subjects. These differences were tested again with the addition of 87 mutants (67 from males) obtained from the etoposide study (![]()
Deletion frequency in females is almost twice as high as in males (Table 5). Mutants from the etoposide study were added, and the data were reanalyzed. Addition of the etoposide mutants further strengthened the significance of the conspicuously uneven distribution of deletions between the sexes (Table 6). An analysis of the regions surrounding the endpoints of these deletions in male and female subjects did not reveal an obvious difference with regard to prevalence of deletions flanked by repeated sequences. Lengths of these intragenic deletions were calculated, and the means were determined. Females had a mean deletion length of 24 ± 65 bp compared with males, who had a mean of 34 ± 84 bp.
|
Characterized splice mutations were obtained disproportionately from males (n = 99) as compared to females (n = 16). This bias likely results from the relative ease of characterizing the single mutant allele in males. To ensure that the bias did not affect the analysis, it was repeated with the exclusion of all splice mutations. The increased frequency of deletions from female over male subjects was confirmed.
Effect of age on spectra:
To facilitate the analysis of age-related effects on mutational specificity, data were subdivided into three different age groups, as described (Table 4), with nearly equal numbers of mutants. Group mean ages were all significantly different from one another. The Monte Carlo test was performed on mutational spectra for the two (spectra shown in Table 5), three, or four partitioning groups (spectra not shown). No differences in spectra were observed for any of the age partitions. Fisher's exact test was used to compare all the classes individually (2 x 2 tables). The A:T
C:G class demonstrated a significant difference in the two (d.f. = 1, two-tailed, P = 0.015), three (d.f. = 2, two-tailed, P = 0.004), and four (d.f. = 3, two-tailed, P = 0.012) age partitions. In each case, frequency of A:T
C:G mutations was significantly lower for the youngest age partition than for the older partitions. For all three sets of comparisons, the observation remained significant after the addition of the 87 etoposide mutants.
Analysis of the distribution of mutation:
Distribution of mutation within the hprt gene was examined for age-related differences. This analysis was based solely upon the distribution of single-base-pair substitutions. Using the Monte Carlo test, the influence of smoking and age in the two-age group partition was examined. No significant differences between spectra were observed during either the smoking or age analysis (results not shown). However, several frequently mutated single-base-pair substitution sites were identified in the mutant dataset. Sites recovered at least eight times were assembled (data not shown), and the effects of smoking, sex, and age were examined using the Monte Carlo test. Several of these frequently mutated sites have been previously identified as hotspot sites for mutation (positions 197, 508, and 617; ![]()
Sites were then tested individually with Fisher's exact test (cell counts for nonevents were dependent upon the site nucleotide). Comparing the spectra obtained from males and females, base substitutions at position 611 are more frequently recovered in females than in males (16 vs. 3%; P = 0.02). The addition of the etoposide data maintained the significance (P = 0.01). Addition of these data was permissible because the etoposide subject group comprised both males and females.
CpG site mutation analysis:
The frequency of G:C
A:T transition mutations occurring at CpG sites was analyzed. The hprt coding sequence contains eight CpG dinucleotides that yield 12 nucleotide positions where a mutation will cause an amino acid substitution or stop codon. From this collection of mutants, only five CpG sites, all coding for arginine, were found mutated. No significant differences (Fisher's exact test) were observed in the frequency of mutations occurring at CpG sites for the smoking/nonsmoking, sex, or age partition comparisons. Previous investigations found a significant strand bias for mutations arising by deamination of the methylated cytosine in the human hprt gene on the nontranscribed strand (![]()
2 = 10.8, d.f. = 1, P < 0.001).
| DISCUSSION |
|---|
T lymphocyte biology and mutant frequency:
The hprt T cell clonal assay depends upon peripheral T cells because of ease of acquisition and because they can be cloned in vitro, which permits mutant selection. As a result, the assay is intimately linked to the biology of T cells (for review see ![]()
![]()
![]()
![]()
Observed hprt mutant frequency is dependent on a number of factors. The rate at which mutation occurs is estimated at 5 x 10-7 mutations per nominal cell division (![]()
Clonal expansion of mutant T cells increases the potential for recovery in the T cell clonal assay. Single mutations, which have not clonally expanded, are nearly undetectable in the current assay, which uses 1040 x 106 cells. Prevalence of mutant clonal expansion in subjects is only evident when sufficient numbers of mutants have been isolated and characterized at the hprt locus and subsequently when mutant characterization indicates a possible clonal run at a TCR locus. This laboratory has previously recognized one large and two smaller clonal runs in a single subject by using such methods (![]()
![]()
![]()
![]()
The kinetics at which clonal expansions are reversed remain unclear. Also unclear is the size of the original clonal pool, which remains as memory cells, and how those memory cells are maintained. An additional complication is the possible selection against hprt mutants that may have a reduced proliferation rate (![]()
![]()
Mutant frequency analysis:
Influence of sex and smoking on hprt MF:
No effect of sex on ln MF was observed, confirming previous reports. Smoking was related to elevated mean ln MF values when compared to nonsmokers. Further examination of the effect of smoking revealed that the increase in ln MF was detectable only in male smokers. This contradicts the findings of ![]()
The effect of smoking on hprt MF remains troublesome. Smoking has a pronounced effect on T lymphocyte populations. Smoking increases the number of peripheral white blood cells by ~30% (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Several suggestions have been presented concerning the smoking-related increase in CD4+ T cells. Smoking may alter cell trafficking by decreasing the ability of the cells to adhere to cellular tissues (marginal pool), thus increasing their relative yield in the peripheral pool (![]()
![]()
![]()
Influence of age on hprt MF:
The results here demonstrate that despite a highly significant overall (ages 085 yr) ln MF vs. age linear relationship, the data do provide for an alternative model. As has been demonstrated previously, ln MF increases rapidly with age in children (![]()
![]()
Rapid increases in MF in children must be related to the nature of their immune systems. Specifically, a juvenile immune system is one that is growing and learning with every encounter with antigen. A newborn child enters an antigen-rich environment, where it must respond to numerous immunological challenges. During growth, the lymphoid tissues increase dramatically in size. These factors must affect hprt MF. In midlife, when the increase in hprt MF is observed to decrease as compared to juveniles, that decrease can be accounted for by both changes in the immune system and reduced antigen encounters. Children are challenged more frequently compared to adults, who encounter relatively fewer novel antigens and have already developed immunity to those encountered previously.
Changes to the immune system, most notably the involution of the thymus (for review see ![]()
![]()
![]()
![]()
![]()
![]()
Mutational spectra analysis:
Influence of smoking:
Using two spectra containing 43 and 55 independent mutants collected from smokers and nonsmokers, respectively, ![]()
T:A transversions, which are produced efficiently by the metabolite benzo[a]pyrene, a tobacco carcinogen (![]()
T:A transversions between the smoking and nonsmoking spectra.
The liability of comparing mutational spectra of limited size is that apparent differences between the spectra may disappear as the spectral size increases. For instance, the apparent mutational "hotspot" (exclusively G:C
A:T transitions at position 617) reported by VRIELING and his colleagues (1992b) in humans occupationally exposed to ethylene oxide (mutants = 18) is frequently mutated in unexposed populations, and some transversions have been recovered at this particular site (![]()
![]()
![]()
To date, this study is the largest comparison of smoking and nonsmoking mutational spectra. Analysis of smoking and nonsmoking spectra using the Adams Skopek Monte Carlo test did not reveal any difference, confirming reports of ![]()
![]()
![]()
![]()
![]()
Influence of sex: The mutant dataset of males is eightfold larger than that of females. This reflects the relative ease of molecular analysis resulting from the male hemizygous state. Despite the disparity in sample size, comparison of base substitution mutational spectra from males and females did not reveal any significant difference. Among 104 mutants recovered from females, a statistically significant (Fisher's test, P = 0.008) increase in the frequency of deletions over that of males was observed. Analysis of the deletion endpoints for both males (n = 59) and females (n = 22) reveals a similar distribution of the breakpoints occurring at repeat and inverted repeat sequences.
An increase in the recovery of small deletions from female subjects is intriguing. It is possible that the difference reflects recombination-mediated repair, as a second copy of the gene is available in females. However, a larger number of mutants from females is needed to better understand the mechanisms involved.
Influence of age:
The question of how age affects mutational specificity was examined by coupling the hprt mutant dataset with subject age. Analysis of several different modes of age partitioning using the Monte Carlo test revealed no significant differences in the complete spectra; however, an increase in the frequency of A:T
C:G transversions with age was observed.
In general, A:T
C:G transversions are relatively rare in mutational spectra. However, several chemical agents have been reported to increase the frequency of this class of transversion. Benzo(a)pyrene's ultimate carcinogenic metabolite, [(+)-BPDE], was found to increase the frequency of this type of transversion in the hprt gene of Chinese hamster cells, but only at low doses (![]()
![]()
C:G transversions in Escherichia coli (5- to 124-fold). The proposed mechanism is the reaction of these hydroxylaminopurines at the O4 position of thymine (![]()
![]()
![]()
C:G transversions cannot be determined.
Another potential mechanism for the origin of A:T
C:G transversions may be linked to oxygen radicals and the polymerase most active in dividing cells. In vitro oxygen-radical-induced mutagenesis was eloquently demonstrated to be DNA polymerase specific (![]()
demonstrated a 14-fold increase in the frequency of A
C transversion as compared to undamaged templates. By comparison, DNA polymerase ß yielded only a 1.5-fold increase. DNA polymerase
accounts for >85% of total DNA polymerase activity in dividing cells, but only 5% in quiescent cells (![]()
C:G transversions can be only speculative at this time.
| CONCLUSIONS |
|---|
The major contribution to hprt mutation occurs early in life even though mutations continue to accumulate at a diminishing rate until the early 50s. After this age, there is no further significant accumulation of mutation. Despite the overall increase in mutation in adults over time, the spectrum of mutation was relatively constant, with the single exception of the frequency of A:T
C:G transversions that increase with age. No evidence was recovered to support any model of aging that predicts mutation rate to accelerate with age. Either most mutations do occur at an early stage in life, or these observations are peculiar to T cells. As the stem cells for the production of T cells are less prolific in old age and T cells themselves apparently divide less vigorously, there are fewer opportunities for mutation. Thus, while the HPRT clonal assay may be the most prominent technique in use for the monitoring of mutation in humans in vivo, it is not necessarily well suited for the purpose. Indeed, neither long-term exposure, such as in the case of tobacco smoking (this study), nor treatment with a powerful chemotherapeutic agent, such as etoposide (![]()
| ACKNOWLEDGMENTS |
|---|
This analysis could not have been accomplished without the international support of research into human mutant frequencies and mutational spectra. We are extremely appreciative of the collaborative efforts of all of the laboratories working in this field for access to their data bases. In addition, we also thank the anonymous donors who provided blood for the assays used in these studies. Statistical support was provided by Dr. Moyra Brackley. Support from the Natural Sciences and Engineering Research Council of Canada, the Medical Research Council, and the Canadian Space Agency is gratefully acknowledged.
Manuscript received October 16, 1998; Accepted for publication March 15, 1999.
| LITERATURE CITED |
|---|
ADAMS, W. T. and T. R. SKOPEK, 1987 Statistical test for the comparision of samples from mutational spectra. J. Mol. Biol. 194:391-396[Medline].
AKIYAMA, M., S. KYOIZUMI, Y. HIRAI, Y. KUSUNOKI, and K. S. IWAMOTO et al., 1995 Mutation frequency in human blood cells increases with age. Mutat. Res. 338:141-149[Medline].
ALBERTINI, R. J., K. L. CASTLE, and W. R. BORCHERDING, 1982 T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. USA 79:6617-6621
ALBERTINI, R. J., L. M. SULLIVAN, J. K. BERMAN, C. J. GREENE, and J. A. STEWART et al., 1988 Mutagenicity monitoring in humans by autoradiographic assay for mutant T-lymphocytes. Mutat. Res. 204:481-492[Medline].
ALBERTINI, R. J., J. P. O'NEILL, J. A. NICKLAS, L. RECIO and T. R. SKOPEK, 1990 hprt mutations in vivo in human T-lymphocytes: frequencies, spectra and clonality, pp. 1524 in Mutation and The Environment. Part C: Somatic and Heritable Mutation, Adduction, and Epidemiology, edited by M. L. MENDELSOHN and R. J. ALBERTINI. Wiley-Liss, Toronto.
ANDERSSON, B., S. FALT, and B. LAMBERT, 1992 Strand specificity for mutations induced by (+)-anti BPDE in the hprt gene in human T-lymphocytes. Mutat. Res. 269:129-140[Medline].
BAARS, P. A., M. M. MAURICE, M. REP, B. HOOIBRINK, and R. A. VAN LIER, 1995 Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27- T cell subset contains specialized primed T cells. J. Immunol. 154:17-25[Abstract].
BACHAND, M., A. M. SEIFERT, and K. MESSING, 1991 Nuclear medicine patients do not have higher mutant frequencies after exposure to thallium-201. Mutat. Res. 262:1-6[Medline].
BODEY, B., B. BODEY, JR., S. E. SIEGEL, and H. E. KAISER, 1997 Involution of the mammalian thymus, one of the leading regulators of aging. In Vivo 11:421-440[Medline].
BOHR, V. A. and R. M. ANSON, 1995 DNA damage, mutation and fine structure DNA repair in aging. Mutat. Res. 338:25-34[Medline].
BRANDA, R. F. and R. J. ALBERTINI, 1995 Effect of dietary components on hprt mutant frequencies in human T-lymphocytes. Mutat. Res. 346:121-127[Medline].
BRANDA, R. F., L. M. SULLIVAN, J. P. O'NEILL, M. T. FALTA, and J. A. NICKLAS et al., 1993 Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat. Res. 285:267-279[Medline].
BURKHART-SCHULTZ, K. J. and I. M. JONES, 1997 Deletion and insertion in vivo somatic mutations in the hypoxanthine phosphoribosyltransferase (hprt) gene of human T-lymphocytes. Environ. Mol. Mutagen. 30:371-384[Medline].
BURKHART-SCHULTZ, K. J., C. B. THOMAS, C. L. THOMPSON, C. L. STROUT, and E. BRINSON et al., 1993 Characterization of in vivo somatic mutations at the hypoxanthine phosphoribosyltransferase gene of a human control population. Environ. Health Perspect. 101:68-74[Medline].
BURKHART-SCHULTZ, K. J., C. L. THOMPSON, and I. M. JONES, 1996 Spectrum of somatic mutation at the hypoxanthine phosphoribosyltransferase (hprt) gene of healthy people. Carcinogenesis 17:1871-1883
CAGGANA, M., H. L. LIBER, P. M. MAUCH, C. N. COLEMAN, and K. T. KESLEY, 1991 In vivo somatic mutation in lymphocytes of Hodgkin's disease patients. Envir. Mol. Mutagen. 18:6-13.
COHEN, S., D. A. J. TYRRELL, M. A. H. RUSSELL, M. J. JARVIS, and M. PHIL et al., 1993 Smoking, alcohol consumption, and susceptibility to the common cold. Am. J. Pub. Health 83:1277-1283
COLE, J. and T. R. SKOPEK, 1994 Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat. Res. 304:33-105[Medline].
COLE, J., M. H. L. GREEN, S. E. JAMES, L. HENDERSON, and H. COLE, 1988 A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutat. Res. 204:493-507[Medline].
COLE, J., M. H. L. GREEN, G. STEPHENS, D. WAUGH, D. BEARE et al., 1990 HPRT somatic mutation data, pp. 2535 in Mutation and The Environment. Part C: Somatic and Heritable Mutation, Adduction, and Epidemiology, edited by M. L. MENDELSOHN and R. J. ALBERTINI. Wiley-Liss, Toronto.
COLE, J., A. P. W. WAUGH, D. M. BEARE, M. SALA-TREPAT, and G. STEPHENS et al., 1991 HPRT mutant frequencies in circulating lymphocytes: population studies using normal donors, exposed groups and cancer-prone syndromes. Prog. Clin. Biol. Res. 372:319-328[Medline].
CORRE, J., J. LELLOUCH, and D. SCHWARTZ, 1971 Smoking and leucocyte counts: results of an epidemiological study. Lancet 2(7725):632-633[Medline].
CURRY, J., A. SKANDALIS, J. HOLCROFT, J. DE BOER, and B. W. GLICKMAN, 1993 Coamplification of hprt cDNA and
T-cell receptor sequences from 6-thioguanine resistant human T-lymphocytes. Mutat. Res. 288:269-275[Medline].
CURRY, J., G. T. ROWLEY, V. SADDI, D. BEARE, and J. COLE et al., 1995 Determination of hprt mutant and mutation frequencies and the molecular characterization of human derived in vivo T-lymphocyte mutants. Environ. Mol. Mutagen. 25:169-179.
CURRY, J., G. BEBB, D. YOUNG, M. KHAIDAKOV, and A. MORTIMER et al., 1997 Similar mutant frequencies observed between pairs of monozygotic twins. Human Mutat. 9:445-451[Medline].
DA CRUZ, A. D, J. CURRY, M. P. CURADO, and B. W. GLICKMAN, 1996 Monitoring hprt mutant frequency over time in T-lymphocytes of people accidentally exposed to high doses of ionizing radiation. Environ. Mol. Mutagen. 27:165-175[Medline].
DAVIES, M. J., D. P. LOVELL, and D. ANDERSON, 1992 Thioguanine-resistant mutant frequency in T-lymphocytes from a healthy human population. Mutat. Res. 265:165-171[Medline].
DEMPSEY, J. L., R. S. SESHADRI, and A. A. MORLEY, 1985 Increased mutation frequency following treatment with cancer chemotherapy. Cancer Res. 45:2873-2877
DUTHIE, S. J, M. ROSS, and A. R. COLLINS, 1995 The influence of smoking and diet on the hypoxanthine phosphoribosyltransferase (hprt) mutant frequency in circulating T-lymphocytes from a normal human population. Mutat. Res. 331:55-64[Medline].
ECKERT, K. A., C. A. INGLE, D. K. KLINEDINST, and N. R. DRINKWATER, 1988 Molecular analysis of mutations induced in human cells by N-ethyl-N-nitrosourea. Mol. Carcinogen. 1:50-56[Medline].
FEIG, D. I. and L. A. LOEB, 1994 Oxygen radical induced mutagenesis is DNA polymerase specific. J. Mol. Biol. 235:33-41[Medline].
FINETTE, B. A., L. M. SULLIVAN, J. P. O'NEILL, J. A. NICKLAS, and P. M. VACEK et al., 1994 Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat. Res. 308:223-231[Medline].
FINETTE, B. A., T. POSENO, P. M. VACEK, and R. J. ALBERTINI, 1997 The effects of maternal cigarette smoke exposure on somatic mutant frequencies at the hprt locus of healthy newborns. Mutat. Res. 377:115-123[Medline].
FREEDMAN, D. S., W. D. FLANDERS, J. J. BARBORIAK, A. M. MALARCHER, and L. GATES, 1996 Cigarette smoking and leucocyte subpopulations in men. Ann. Epidemiol. 6:299-306[Medline].
FUSCOE, J. C., L. J. ZIMMERMAN, M. J. LIPPERT, J. A. NICKLAS, and J. P. O'NEILL et al., 1991 V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res. 51:6001-6005
FUSCOE, J. C., L. J. ZIMMERMAN, K. HARRINGTON-BROCK, L. BURNETTE, and M. M. MOORE et al., 1992 V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans. Mutat. Res. 283:13-20[Medline].
GEORGE, A. J. T. and M. A. RITTER, 1996 Thymic involution with ageing: obsolescence of good housekeeping? Immunol. Today 17:267-272[Medline].
GLOBERSON, A., 1995 T lymphocytes and aging. Int. Arch. Allergy Immunol. 107:491-497[Medline].
GREENE, M. H, J. P. O'NEILL, and J. COLE, 1995 Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat. Res. 334:323-339[Medline].
GRIST, S. A., M. MCCARRON, A. KUTLACA, D. R. TURNER, and A. A. MORLEY, 1992 In vivo human somatic mutation: frequency and spectrum with age. Mutat. Res. 266:189-196[Medline].
GRUBECK-LOEBENSTEIN, B., 1997 Changes in the aging immune system. Biologicals 25:205-208[Medline].
GUTTENPLAN, J. B., 1990 Mutagenesis by N-nitroso compounds: relationships to DNA adducts, DNA repair, and mutational efficiencies. Mutat. Res. 233:177-187[Medline].
GUTTERIDGE, J. M. C., 1992 Ageing and free radicals. Med. Lab. Sci. 49:313-318[Medline].
HAKODA, M., M. AKIYAMA, S. KYOIZUMI, A. A. AWA, and M. YAMAKIDO et al., 1988 Increased somatic cell mutant frequency in atomic bomb survivors. Mutat. Res. 201:39-48[Medline].
HARMAN, D., 1992 Free radical theory of aging. Mutat. Res. 275:257-266[Medline].
HENDERSON, L., H. COLE, J. COLE, S. E. JAMES, and M. GREEN, 1986 Detection of somatic mutations in man: evaluation of the microtitre cloning assay for T-lymphocytes. Mutagenesis 1:195-200
HIRAI, Y., Y. KUSUNOKI, S. KYOIZUMI, A. A. AWA, and D. J. PAWEL et al., 1995 Mutant frequency at the HPRT locus in peripheral blood T-lymphocytes of atomic bomb survivors. Mutat. Res. 329:183-196[Medline].
